
6th
Spring Pharmaceutical Synchrotron X-Ray Powder Diffraction Conference
6th-8th May 2026
|
BY PUBLIC TRANSPORT:
|
BY WALK:
40 MINS from Basel SBB (central) station |
BY CAR:
|
TO BE DEFINED
DAY 1 - 6TH MAY 2026
| 00 – 8:30 | Get Together Breakfast and Registration |
|
8:30 – 9:00
9:00 - 9:15 |
Welcome address from NOVARTIS Despina Solomonidou, EVP, Global Head Technical Research & Development at Novartis
Organizers' Opening Remarks: SPS-XRPD-6 |
|
9:15 – 10:30 |
PLENARY LECTURE (60min talk+15min Q&A)
FROM CRYSTAL STRUCTURE PREDICTION TO SOLID-FORM CONTROL - Marcus NEUMANN - Avant-Garde Materials Simulation, Germany - Chair: TBC
|
|
10:30 – 11:00
|
Coffee break and Networking
|
|
11:00 – 12:30
|
NEW TRENDS IN SYNCHROTRON-BASED SCATTERING TECHNIQUES FOR PHARMACEUTICAL SOLIDS - PART 1 (30min talk+15min Q&A) - Chair: TBC
Synchrotron XRPD for Advanced Structural Analysis: Applications, Capabilities, and Emerging Developments - Fabia GOZZO, Excelsus Structural Solutions, Switzerland
High-Throughput X-Ray Powder Diffraction - TBC |
| 12:30 - 13:45 | Networking Lunch |
|
14:00 - 15:30 |
NEW TRENDS IN SYNCHROTRON-BASED SCATTERING TECHNIQUES FOR PHARMACEUTICAL SOLIDS - PART 2 (30min talk+15min Q&A) - Chair: TBC
Visualizing Polymorphic Transformations in Pharmaceutical Tablets - Iain D. H. OSWALD, University of Strathclyde, UK
Pair Distribution Function applied to Pharmaceuticals- Rocco CALIANDRO, CNR - Bari - Italy
|
| 15:30 - 16:15 | Coffee Break and Networking |
|
16:15 - 18:30 |
NEW TRENDS IN ADVANCED TECHNIQUES COMPLEMENTARY TO SYNCHROTRON XRPD (30min talk+15min Q&A) - Chair: TBC
SAXS/USAXS in Pharma — Synchrotron Bio-SAXS: Advanced Modelling for the Structural Characterization of Biopharmaceuticals/Drug Delivery Systems - Dmitri SVERGUN (EMBL @ DESY, bioSAXS company)
Solid-State NMR — Local environments & H-bonding; how ss-NMR constraints refine XRPD-led models - Lyndon EMSLEY- Swiss Federal Institute of Technology (EPFL), Lausanne, Switzerland
Electron Diffraction (3D-ED/MicroED) — 3D Electron Diffraction for Pharmaceutical Nanocrystals: When and How It Complements Synchrotron XRPD - Gustavo SANTISO, ELDICO, Switzerland
|
| 19:00 - ON |
CONFERENCE DINNER |
DAY 2 - 7TH MAY 2026
| 8:30 – 9:00 | Get Together Breakfast |
|
9:00 – 11:00 |
ROLE OF POLYMORPSHISM IN INTELLECTUAL PROPERTY RIGHTS - (25min + 5min Q&A) - Chair: tbc
Combining Techniques for Patent Protection and Litigation Purposes - TBC -
Patent Litigation in the Pharmaceutical Sector: Practical Perspectives from Long-Term Practice - Einar STOLE -Covington & Burling, Washington, USA
Artificial Intelligence and §112 Requirements: Implications for Chemical Structures and Protein Folding - Rebecca Horwitz - BartlitBeck LLP, USA
Proving Polymorph Patent Infringement: The Role of Synchrotron XRPD - TBC |
| 11:00 – 11:30 | Coffee Break & Networking |
|
11:30 – 12:15
|
Round Table Discussion on Intellectual Properties |
| 12:15 – 13:45 | Networking Lunch |
|
14:00 – 15:30 |
MULTIMODAL APPROACH TO PHARMACEUTICALS CHARACTERIZATION AND CASE STUDIES ( 25min + 5min Q&A) - Chair: TBC
Synchrotron XRPD as an Anchor Technique for Integrated Pharmaceutical Characterization - TBC
Single Crystal XRD - TBC
Using Orthogonal Techniques to Probe for Detectable Crystalline API in Amorphous Dispersions - Pam Smith & Ruba Alajlouni - Improved Pharma, USA |
|
15:30 – 16:00
|
2 COMMERCIAL PERFORMANCES UPDATES FROM PROFESSIONALS (15MIN EACH) |
| 16:00 - 17:00 | Coffee Break and Networking |
|
17:00 - 18:30 pm
|
TECHNIQUES AND METHODOLOGIES DEVELOPMENTS ( 25min + 5min Q&A) - Chair: TBC
High-Throughput Beyond Data Collection: Integrated Sample Preparation, Experiment Design, and Data Analysis - Vincenzo CAROPRESE and Mads CARLSEN - Excelsus Structural Solutions, Switzerland
2 TALKS SELECTED FROM ABSTRACT SUBMISSIONS
|
|
|
DAY 3 - 8TH MAY 2026
| 8:30 – 9:00 | Get Together Breakfast |
|
9:00 – 10:30 |
SAXS & SANS: STRUCTURAL CHARACTERIZATION OF BIOPHARMACEUTICALS AND ADVANCED MODELLING - PART 1 (25min + 5min Q&A) - Chair: TBC
An advanced synchrotron USAXS-SAXS-WAXS and XPCS instrument for probing complex biopharmaceutical systems- Theyencheri NARAYANAN, European Synchrotron Radiation Facility - Grenoble, France
An advanced multipurpose SAXS beamline for probing the structure and dynamics of (bio)pharmaceuticals - Fátima HERRANZ- MAX IV - Lund, Sweden
Advances in SAXS & SANS modelling for the structural characterization of biopharmaceuticals and drug-delivery systems - Boyang ZHOU, Excelsus Structural Solutions - Switzerland |
| 10:30 – 11:00 | Coffee Break & Networking |
|
11:00 – 12:30 |
SAXS & SANS: STRUCTURAL CHARACTERIZATION OF BIOPHARMACEUTICALS AND ADVANCED MODELLING - PART 2
3 TALKS SELECTED FROM ABSTRACT SUBMISSIONS
|
| 12:30 – 14:00 | Lunch Break & Networking |
|
14:00 – 15:30 |
PAIR DISTRIBUTION FUNCTION MEASUREMENTS AND ANALYSIS ( 25min + 5min Q&A) - Chair: TBC
Is a domain size of 10 nm sufficient for structure determination of nanocrystalline organic compounds from powder data? - Martin PIEPENBRING (born SCHMIDT), Goethe University Frankfurt - Germany
Recent developments in modeling amorphous pharmaceuticals - Chris BENMORE, Argonne National Laboratory - USA
|
|
|
|
| 15:30 – 16:00 | Coffee Break |
|
16:00 - 17:30 |
PAIR DISTRIBUTION FUNCTION MEASUREMENTS AND ANALYSIS - ( 25min + 5min Q&A) - Chair:TBC
2 TALKS SELECTED FROM ABSTRACT SUBMISSIONS
|
|
17:30 – 17:45
|
Closing: Fabia GOZZO & Arnaud GRANDEURY |
Fabia Gozzo is a physicist with over 30 years of experience in synchrotron-based X-ray diffraction. After research positions at Lawrence Berkeley National Laboratory, Intel, and the Paul Scherrer Institute—where she developed one of the world's leading powder diffractometers—she founded Excelsus Structural Solutions to bring advanced synchrotron analytics to industry. She has authored over 90 scientific publications and is internationally recognized as an expert and advisor in synchrotron-based structural characterization.
MS in Physics, University of Bari, Italy
PhD in Physics, EPFL, Lausanne, Switzerland
Synchrotron X-Ray Powder Diffraction (XRPD) enables a level of structural insight that extends well beyond routine phase identification. This presentation will concentrate on advanced detection and quantification methodologies, including trace-level crystalline phase analysis and robust quantitative phase assessment performed with synchrotron accuracy and carefully designed calibration strategies.
Recent methodological developments, including high-throughput synchrotron XRPD workflows, will be briefly discussed as part of a broader effort to combine analytical rigor with efficiency, without compromising data quality. These advances expand the practical applicability of synchrotron XRPD while maintaining the resolution, sensitivity, and reliability required for complex pharmaceutical materials.
An overview of additional capabilities and emerging developments will be provided, including applications relevant to intellectual property and legal contexts, where structurally sound and quantitatively defensible data are essential.
Dr. Dmitry I. Svergun
Education/degrees
1980: MSc in Solid state physics, Physics Department, Moscow State University, Moscow, Russia
1982: PhD in Physics and Mathematics, Institute of Crystallography (ICRAS), Moscow, Russia,
1997: Dr. Science in Physics and Mathematics (advanced degree), ICRAS, Moscow, Russia
Employment
1980-2008: Engineer, Researcher, Senior Scientist, ICRAS, Moscow, Russia.
1990-1991: Guest scientist, GKSS Research Center, Geesthacht, Germany.
1991-2022: Visiting fellow, Staff Scientist, Team Leader, Group Leader, Senior Scientist, Joint Head of Research Infrastructures, European Molecular Biology Laboratory, Hamburg Unit, Germany
2014-now: CEO, BIOSAXS GmbH, Hamburg, Germany
Specialization: Structure analysis of condensed matter, in particular, biopolymers in solution, by scattering of X-rays and neutrons; Numerical methods, programming, biophysics.
Honors and awards
2010: International Rusnanoprize for methods development in nanodiagnostics
2018: International Guinier prize for lifetime achievements in small-angle scattering
Publications: over 1000 scientific papers, reviews and book chapters, 3 monographs, h-index over 110.
Small-angle X-ray scattering (SAXS) is a powerful technique for the investigation of biological macromolecules in solution and nanostructured systems. It enables the structural analysis of native particles and complexes and allows rapid assessment of structural changes induced by variations in external conditions. The development of dedicated high-brilliance synchrotron beamlines and advanced data collection and analysis methodologies has significantly enhanced the resolution and reliability of SAXS-based structural models. A key strength of SAXS lies in its ability to quantitatively characterize complex systems under native conditions, thereby enabling the observation of biomolecules in action through real-time monitoring of their responses to changes in physical and chemical parameters, such as pH, temperature, or ligand binding.
Although SAXS typically provides low-resolution quaternary structural information, it is uniquely suited for the analysis of equilibrium mixtures and for the visualization of flexible or disordered regions that are often inaccessible to high-resolution techniques. Furthermore, SAXS can be readily integrated with computational, biophysical, and biochemical methods. In hybrid modeling approaches, it effectively incorporates high-resolution structural information obtained from crystallography, NMR spectroscopy, cryo-electron microscopy, and AlphaFold predictions.
In this presentation, modern SAXS data analysis methodologies implemented in the comprehensive software package ATSAS will be introduced. Particular emphasis will be placed on SAXStant, a novel ATSAS-based artificial intelligence tool designed to assist users in extracting structural information from experimental scattering data. The application of these methods will be demonstrated through selected examples highlighting the structural characterization and conformational transitions of pharmaceutically relevant macromolecules and complexes in solution.
